• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病家族史、心理应激源和烟草使用与肿瘤坏死因子-α抑制剂诱导的银屑病的发生有关:一项病例对照研究。

Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-α inhibitor-induced psoriasis: A case-control study.

机构信息

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio.

Case Western Reserve University School of Medicine, Cleveland, Ohio.

出版信息

J Am Acad Dermatol. 2020 Dec;83(6):1599-1605. doi: 10.1016/j.jaad.2020.06.081. Epub 2020 Jun 25.

DOI:10.1016/j.jaad.2020.06.081
PMID:32592879
Abstract

BACKGROUND

Tumor necrosis factor-α inhibitor-induced psoriasis (TNFI psoriasis) is a paradoxical reaction characterized by development of a psoriasiform rash that mimics psoriasis vulgaris. Temporal onset variability and low incidence rates suggest that underlying risk factors or outside triggers have a role in TNFI psoriasis initiation.

OBJECTIVES

We aimed to identify underlying risk factors and outside triggers associated with TNFI psoriasis onset.

METHODS

This case-control study included 97 patients at a tertiary care center between 2003 and 2013 who developed TNFI psoriasis. Ninety-seven control patients were matched to age, sex, disease, TNF-α inhibitor, and length of time on treatment before TNFI psoriasis onset. Patient medical records were reviewed ≥6 months immediately preceding TNFI psoriasis onset (similar equivalent time point for matched controls) for information about potential risk factors and outside factors categorized as: (1) serologic abnormalities, (2) acute events, and (3) social factors.

RESULTS

Compared with those of matched controls, odds ratios (ORs) were significantly higher in the TNFI psoriasis group for psoriasis family history (OR, 16.0) and acute psychological stressors (OR, 3.14) and marginally associated with tobacco use (OR, 1.76).

CONCLUSIONS

Our results suggest that psoriasis family history, psychological stressors, and tobacco use might be risk factors for developing TNFI psoriasis. Performing detailed patient histories when considering TNFI therapy may be useful in identifying patients at risk for TNFI-psoriasis.

摘要

背景

肿瘤坏死因子-α 抑制剂诱导的银屑病(TNFI 银屑病)是一种矛盾的反应,表现为出现类似于寻常型银屑病的银屑病样皮疹。其发病时间的可变性和低发生率表明,潜在的危险因素或外部诱因在 TNFI 银屑病的发病中起作用。

目的

我们旨在确定与 TNFI 银屑病发病相关的潜在危险因素和外部诱因。

方法

本病例对照研究纳入了 2003 年至 2013 年间在一家三级护理中心发生 TNFI 银屑病的 97 例患者。97 例对照患者按年龄、性别、疾病、TNF-α 抑制剂和 TNFI 银屑病发病前的治疗时间进行匹配。回顾患者病历,以获取发病前 6 个月(匹配对照患者为发病前相似的等效时间点)的潜在危险因素和外部因素信息,这些因素分为:(1)血清学异常,(2)急性事件,和(3)社会因素。

结果

与匹配对照患者相比,TNFI 银屑病组发生银屑病家族史(OR 16.0)和急性心理应激(OR 3.14)的比值比(OR)显著更高,且与吸烟(OR 1.76)有轻微关联。

结论

我们的结果表明,银屑病家族史、心理应激和吸烟可能是发生 TNFI 银屑病的危险因素。在考虑 TNFI 治疗时进行详细的患者病史评估可能有助于识别发生 TNFI 银屑病的高危患者。

相似文献

1
Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-α inhibitor-induced psoriasis: A case-control study.银屑病家族史、心理应激源和烟草使用与肿瘤坏死因子-α抑制剂诱导的银屑病的发生有关:一项病例对照研究。
J Am Acad Dermatol. 2020 Dec;83(6):1599-1605. doi: 10.1016/j.jaad.2020.06.081. Epub 2020 Jun 25.
2
TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic.TNF-α 抑制剂诱导的银屑病:克利夫兰诊所十年经验。
J Am Acad Dermatol. 2020 Dec;83(6):1590-1598. doi: 10.1016/j.jaad.2018.12.018. Epub 2018 Dec 18.
3
Tumor necrosis factor-α inhibitor-induced psoriasis in juvenile idiopathic arthritis patients.肿瘤坏死因子-α抑制剂诱发幼年特发性关节炎患者出现银屑病。
Pediatr Dermatol. 2019 Sep;36(5):613-617. doi: 10.1111/pde.13859. Epub 2019 Jun 25.
4
Histologic comparison of tumor necrosis factor-α inhibitor-induced psoriasis and psoriasis vulgaris.肿瘤坏死因子-α抑制剂诱导的银屑病与寻常型银屑病的组织学比较。
J Am Acad Dermatol. 2020 Jul;83(1):71-77. doi: 10.1016/j.jaad.2020.01.006. Epub 2020 Jan 11.
5
Absolute and Relative Risk of New-Onset Psoriasis Associated With Tumor Necrosis Factor-α Inhibitor Treatment in Patients With Immune-Mediated Inflammatory Diseases: A Danish Nationwide Cohort Study.接受肿瘤坏死因子-α抑制剂治疗的免疫介导性炎症疾病患者新发银屑病的绝对和相对风险:一项丹麦全国队列研究。
JAMA Dermatol. 2022 Sep 1;158(9):997-1004. doi: 10.1001/jamadermatol.2022.2360.
6
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis.肿瘤坏死因子拮抗剂治疗诱导的银屑病皮损:临床特征及可能的免疫发病机制。
Semin Arthritis Rheum. 2010 Dec;40(3):233-40. doi: 10.1016/j.semarthrit.2010.04.003. Epub 2010 Jun 26.
7
Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations.进行回顾性分析以描述肿瘤坏死因子α抑制剂与慢性阻塞性肺疾病(COPD)相关住院之间的关联。
Int J Chron Obstruct Pulmon Dis. 2017 Jul 19;12:2085-2094. doi: 10.2147/COPD.S127815. eCollection 2017.
8
Paradoxical Psoriasis in Children Receiving Anti-TNFα Treatment for Inflammatory/autoimmune Disease.接受抗TNFα治疗的炎症性/自身免疫性疾病儿童中的矛盾性银屑病。
Paediatr Drugs. 2021 Mar;23(2):131-141. doi: 10.1007/s40272-021-00440-8. Epub 2021 Mar 24.
9
No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.使用日本健康保险数据库的流行病学研究:类风湿关节炎患者使用肿瘤坏死因子抑制剂和非肿瘤坏死因子抑制剂并无增加带状疱疹风险
Int J Rheum Dis. 2018 Sep;21(9):1670-1677. doi: 10.1111/1756-185X.13300. Epub 2018 Apr 17.
10
Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?肿瘤坏死因子抑制剂会增加慢性免疫介导的炎症性疾病患者的癌症风险吗?
Cytokine. 2018 Jan;101:78-88. doi: 10.1016/j.cyto.2016.09.013. Epub 2016 Sep 26.

引用本文的文献

1
Association between body roundness index and psoriasis: a cross-sectional study.身体圆润度指数与银屑病之间的关联:一项横断面研究。
Sci Rep. 2025 Mar 28;15(1):10796. doi: 10.1038/s41598-025-91814-2.
2
The Impact of Family History on Clinical Presentation and Biologic Treatment Response in Patients with Psoriasis: A Multicenter Prospective Cohort Study.家族史对银屑病患者临床表现及生物治疗反应的影响:一项多中心前瞻性队列研究
Am J Clin Dermatol. 2025 Mar;26(2):291-300. doi: 10.1007/s40257-025-00918-y. Epub 2025 Jan 22.
3
Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic Factors.
肿瘤坏死因子抑制剂治疗患者的矛盾性银屑病:潜在发病机制和遗传因素的作用。
Int J Mol Sci. 2024 Jun 27;25(13):7018. doi: 10.3390/ijms25137018.
4
Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report.乌司奴单抗诱导的矛盾性银屑病:全面综述及病例报告。
Medicina (Kaunas). 2024 Jan 6;60(1):106. doi: 10.3390/medicina60010106.
5
Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?矛盾性银屑病:特发性银屑病的另一面还是一种自发可逆的药物反应?
J Transl Autoimmun. 2023 Sep 6;7:100211. doi: 10.1016/j.jtauto.2023.100211. eCollection 2023 Dec.
6
Risk Factors of Ixekizumab-Induced Injection Site Reactions in Patients with Psoriatic Diseases: Report from a Single Medical Center.银屑病患者中司库奇尤单抗诱导的注射部位反应的危险因素:来自单一医学中心的报告
Biomedicines. 2023 Jun 15;11(6):1718. doi: 10.3390/biomedicines11061718.
7
Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis.接受 TNF 治疗的炎症性肠病患者发生矛盾性银屑病或银屑病样病变的发生率及危险因素:系统评价和荟萃分析。
Front Immunol. 2022 Mar 1;13:847160. doi: 10.3389/fimmu.2022.847160. eCollection 2022.
8
Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers.抗 TNF-α 治疗诱导的矛盾性银屑病:疾病特异性临床和遗传标志物的评估。
Int J Mol Sci. 2020 Oct 23;21(21):7873. doi: 10.3390/ijms21217873.